Role of Specialty Pharmacy
Sonali Acharya, PharmD. will explain the role of specialty pharmacies. We will discuss accreditation requirements for specialty pharmacies, process to determine which medications are considered specialty and specifically the benefits of a healthcare system specialty pharmacy.
Category
  • Patient Centered Care
Format
  • Self-Paced, Online Courses
Credits
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
Let’s Take a BiTE Out of CRS and Neurotoxicity
Immunotherapy has made tremendous progress as cancer-directed therapy has evolved, particularly in the field of T cell-engaging therapies. Common and serious side effects of these types of therapies include Cytokine Release Syndrome (CRS) and Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS). Join us as Bejal Kikani, MSN, FNP-BC, WHNP-BC, discusses the recognition, grading, and treatment of these toxicities.
Category
  • Advanced Practice Provider
Format
  • Self-Paced, Online Courses
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 NCPD/CNE
  • 1.00 Participation
Peritoneal Carcinomatosis: The Good, the Bad, and the Ugly
Jeremiah 'Jig' Deneve, DO, FACS, provides an overview of the natural history, treatment, and outcome for peritoneal carcinomatosis.
Category
  • Advanced Practice Provider
Format
  • Self-Paced, Online Courses
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 NCPD/CNE
  • 1.00 Participation
CAR-T 101: Overview of CAR-T Therapy and Management of Toxicities
Megan McElfresh, PA-C, will review chimeric antigen receptor therapy, associated side effects, and the treatment or prevention of side effects.
Category
  • Advanced Practice Provider
Format
  • Self-Paced, Online Courses
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 NCPD/CNE
  • 1.00 Participation
Lung Cancer Screening Essentials
This multidisciplinary Panel Presentation will describe the importance of CT-based lung cancer screening, indications and criteria for screening, the optimal structure and requirements of a screening program, and the current state of screening at UNC. We will present practical information relevant to providers who may order screening CT and/or may discuss screening with patients.
Category
  • Advanced Practice Provider
Format
  • Self-Paced, Online Courses
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 NCPD/CNE
  • 1.00 Participation
Oncologic Emergencies: Superior Vena Cava Syndrome, Hypercalcemia, and SIADH
Allison Phillips, MPAP, MHPE, PA-C, reviews the clinical manifestations, underlying causes, and management of some of the most common emergencies facing patients undergoing cancer treatment, including Superior Vena Cava Syndrome, Hypercalcemia, and SIADH.
Category
  • Advanced Practice Provider
Format
  • Self-Paced, Online Courses
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 NCPD/CNE
  • 1.00 Participation
Update on Prostate Cancer Screening
Marc Bjurlin, DO, MSc, FACOS, gives a contemporary overview of prostate cancer screening with a focus on prostate cancer in men in North Carolina.
Category
  • Research to Practice
Format
  • Self-Paced, Online Courses
Credits
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
Genitourinary Cancer Management in North Carolina
Hung-Jui Tan, MD, MSHPM, will review recent practice-changing research and new management recommendations for patients with prostate, kidney, bladder, and testicular cancer.
Category
  • Research to Practice
Format
  • Self-Paced, Online Courses
Credits
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit™
  • 1.25 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
Sarcoma Management in North Carolina: Updates for 2023
Mark Woodcock gives a broad overview of the multidisciplinary approaches for the treatment of soft tissue sarcomas in adults, and detailed updates in management with systemic therapies. Specific attention is paid to sarcoma sub-types which may warrant special considerations.
Category
  • Research to Practice
Format
  • Self-Paced, Online Courses
Credits
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
H. Pylori Testing and Treatment for Gastric Cancer Prevention
Katherine Garman, MD, and Meira Epplein, PhD, will provide information on gastric cancer and important risk factors such as H. pylori infection. We will describe some of the racial disparities associated with gastric cancer in the US, highlighting those that are relevant for North Carolina. We will also discuss H. pylori as a modifiable risk factor and we will review current guidelines on H. pylori testing, treatment, eradication testing, and the growing problem of antibiotic resistance.
Category
  • Research to Practice
Format
  • Self-Paced, Online Courses
Credits
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ASRT
  • 1.00 NCPD/CNE
  • 1.00 Participation

Pages